Jimmy Mengel’s “Delta-9” — is it “One Drug to End All Pain — Naturally?”

What tickers are The Crow's Nest pitching as "Delta-9" Stocks?

By Travis Johnson, Stock Gumshoe, December 11, 2014

“The Greatest Medical Breakthrough in 72 Years…

“One Drug to End All Pain — Naturally

“A new revolutionary drug called ‘Delta-9’ will send a small group of companies skyrocketing for life-altering gains… starting December 31, 2014.

“The last time something like this happened 72 years ago… investors had the opportunity to turn every $1,000 into $1,640,000.”

That’s the intro from Jimmy Mengel’s ad, he’s trying to get you to sign up for a subscription to The Crow’s Nest, his stock-picking newsletter put out by Angel Publishing.

And it’s all about something he calls “Delta-9” …

“This new ‘Delta-9’ drug could make all of that a reality.

“20,000 independent studies have confirmed its efficacy.

“105 of these were peer-reviewed clinical studies.

“And they found…

“It is more effective than any single painkiller or narcotic out there.

“It relieves pain for longer periods of time — without dangerous side effects.

“It significantly reduces the need for ANY painkillers — to the point of zero.”

Sound exciting? Sure! That’s why we decided to figure out what he’s talking about. Here’s the immediate promise of riches for you:

“On December 31, 2014, scientists are releasing the results of phase III clinical trials for ‘Delta-9.’

“Results that could send the handful of companies pioneering its development through the roof.

“Using history as a guide, you could see nothing short of 164,000% gains….

“Today, I’ll reveal the three companies at the cutting edge of what could be the most groundbreaking discovery in modern medicine.

“These are companies you can buy into right now for astronomical gains… including one that’s set to release a ‘Delta-9’ drug into pharmacies across the country by December 31.”

Mengel goes on to compare the potential of this “Delta-9” drug to penicillin, which he says made Pfizer and Merck such huge winners after they went public in the World War II era — generating possible gains like turning, he says, $100 into $2.4 million in the case of Pfizer (I haven’t checked those numbers).

And he talks about some lofty potential for the drug:

“And it could not only end all pain…

Are you getting our free Daily Update
"reveal" emails? If not,
just click here...


“But also reverse the symptoms of common diseases.

“Diseases like:

  • Cancer
  • Epilepsy
  • Neuropathy
  • Multiple sclerosis
  • Fibromyalgia
  • Back pain
  • Type 2 diabetes
  • Schizophrenia
  • Post-traumatic stress disorder (PTSD)

These are big markets. And the list goes on and on.”

And that it will help get rid of the problem of opioid addiction (which in turn has become a heroin problem as well, at least in our part of the country)…

“‘Delta-9’ is not just a potential replacement for prescription painkillers…

“It’s a potential addiction treatment, too!

“Mind you, this is a natural painkiller with virtually zero dangerous side effects or addictive properties.

“Once this goes on the market, it could rapidly wipe out the entire $9.4 billion painkiller industry.

“I’m talking about the end of Oxycontin, Oxycodone, Demerol, and other dangerous drugs.

“It could disrupt and shake Big Pharma at its foundation.”

So what is it?

Cannabis. Mary jane. Grass. Ganja. He’s talking about marijuana… and, presumably, about marijuana stocks — many of which have captured the public imagination over the past year or so in the wake of the continuing progress of marijuana decriminalization and legalization for both medical and recreational purposes. Delta-9-tetrahydrocannabinol is, if you want more detail, the psychoactive compound in the marijuana plant (usually called Delta-9-THC, or just THC).

Will it change the world, like penicillin did? Will the current crop of marijuana stocks be looked back on as the “next Pfizer” or the ̶